基因扩增技术市场规模、份额和成长分析（按产品、样本类型、技术、最终用户和地区）- 产业预测 2025-2032

2023 年全球基因扩增技术市场规模价值 281 亿美元，预计将从 2024 年的 301 亿美元成长到 2032 年的 521 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.1%。

在分子生物学和诊断方法创新的推动下，全球基因扩增技术市场正经历显着成长。推动这一趋势的关键因素包括这​​些技术在疾病诊断、个人化医疗和生物技术研究中的应用日益广泛。市场由聚合酵素链锁反应(PCR) 和等温扩增技术主导，而基于 CRISPR 的扩增正成为一个引人注目的竞争对手。在广泛的研发计划和强大的医疗保健框架的支持下，北美保持着相当大的市场占有率。同时，由于医疗支出的增加和技术的进步，亚太地区正在经历快速成长。随着基因组学领域继续彻底改变医学和研究应用，基因扩增技术市场预计将保持成长轨迹。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

基因扩增技术市场规模（依产品划分）

• 市场概况
• 装置
• 套件和试剂
• 软体和服务

基因扩增技术市场规模（依样本类型）

• 市场概况
• 细胞株
• 农业和食品复製品
• 体液
• 组织
• 其他的

基因扩增技术市场规模（依技术划分）

• 市场概况
• PCR 扩增
• 恒温环型核酸扩增
• 基于核酸序列的扩增
• 链置换扩增
• 多重置换放大
• 滚环扩增
• 分支扩增
• 其他的

基因扩增技术市场规模（依最终用户划分）

• 市场概况
• 製药和生物技术公司
• 学术及研究机构
• 医院和诊断实验室
• 合约研究组织
• 法医学实验室
• 其他的

基因扩增技术市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• QIAGEN（Germany）
• New England Biolabs（United States）
• Illumina Inc.（United States）
• Yikang Gene（China）
• Bio-Rad Laboratories（United States）
• Menarini Silicon Biosystems（Italy）
• Merck KGaA（Germany）
• Promega Corporation（United States）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• 4basebio AG（Germany）
• LGC Group（United Kingdom）
• Vazyme Biotech Co. Ltd.（China）
• MyBioSource（United States）
• 10x Genomics（United States）
• Ginkgo Bioworks（United States）
• Thermo Fisher Scientific（United States）
• Agilent Technologies（United States）
• Roche Diagnostics（Switzerland）
• Becton, Dickinson and Company（United States）

结论和建议

Global Gene Amplification Technologies Market size was valued at USD 28.1 billion in 2023 and is poised to grow from USD 30.1 billion in 2024 to USD 52.1 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global gene amplification technologies market is witnessing substantial growth, spurred by innovations in molecular biology and diagnostic methodologies. Major factors driving this trend include the escalating use of these technologies in disease diagnosis, personalized medicine, and biotechnology research. Dominating the market are polymerase chain reaction (PCR) and isothermal amplification techniques, with CRISPR-based amplification emerging as a notable contender. North America maintains a significant market share, bolstered by extensive R&D initiatives and a robust healthcare framework. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increased healthcare spending and technological advancements. As the field of genomics continues to revolutionize medical and research applications, the gene amplification technologies market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segments Analysis

Global Gene Amplification Technologies Market is segmented by Product, Sample Type, Technology, End-user and region. Based on Product, the market is segmented into Instruments, Kits and Reagents and Software & Services. Based on Sample Type, the market is segmented into Cell Lines, Agricultural & Food Samples, Body Fluids, Tissue and Others. Based on Technology, the market is segmented into PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic-Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, Hospitals & Diagnostic Labs, Contract Research Organizations, Forensic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth driven by the rising demand for personalized medicine and the ongoing advancements in biotechnology. These innovative technologies facilitate precise and efficient analysis of genetic material, which is crucial for both diagnostic and research applications. As healthcare increasingly shifts toward tailored treatments and diagnostic methods, the need for accurate gene amplification solutions is surging. This trend underscores the importance of gene amplification technologies in enabling researchers and clinicians to better understand genetic information and develop effective, individualized healthcare strategies, further fueling the expansion of this dynamic market.

Restraints in the Global Gene Amplification Technologies Market

The Global Gene Amplification Technologies market faces several restraints that may impede its growth and broader acceptance. Ethical issues related to genetic manipulation create significant apprehension among stakeholders, while complicated regulatory frameworks add layers of complexity and uncertainty to the development and commercialization processes. Additionally, the high costs associated with implementing gene amplification technologies can deter investment and adoption, further limiting their reach and potential impact. Collectively, these factors contribute to challenges in expanding the market, making it essential for industry players to navigate these obstacles effectively to promote growth and innovation within this vital sector.

Market Trends of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth, driven by advancements in CRISPR-Cas9 technology, which enables precise and efficient gene editing. The increasing applications of these technologies in medical research, agriculture, and biotechnology are further driving expansion. The rise of synthetic biology and personalized medicine is fueling demand for innovative gene amplification tools, while automation and high-throughput capabilities enhance operational efficiency. Despite ethical and regulatory challenges concerning genetic manipulation, the market's trajectory is propelled by continuous innovation, diverse applications, and increased investment in genetic research, focusing on both therapeutic and non-therapeutic applications. This trend underscores the critical role of gene amplification technologies in shaping the future of various industries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Gene Amplification Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits and Reagents
• Software & Services

Global Gene Amplification Technologies Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Cell Lines
• Agricultural & Food Samples
• Body Fluids
• Tissue
• Others

Global Gene Amplification Technologies Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic-Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Rolling Circle Amplification
• Ramification Amplification
• Others

Global Gene Amplification Technologies Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Hospitals & Diagnostic Labs
• Contract Research Organizations
• Forensic Labs
• Others

Global Gene Amplification Technologies Market Size & CAGR (2025-2032)

• North America (Product, Sample Type, Technology, End-user)
  • US
  • Canada
• Europe (Product, Sample Type, Technology, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample Type, Technology, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample Type, Technology, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample Type, Technology, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yikang Gene (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 4basebio AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vazyme Biotech Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations